Valquest Partners logo

Valquest Partners

Asia, Beyrouth, Lebanon, Beirut

Description

By leveraging its partners’ substantial financial, operational, transactional, and industry resources and related experience,

Investor Profile

Valquest Partners has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 67% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in France, Switzerland.
  • Strong thematic focus on Biotechnology, Health Care, Medical Device.
  • Led 1 rounds in the past year.

Stage Focus

  • Series B (33%)
  • Series Unknown (33%)
  • Series A (33%)

Country Focus

  • France (67%)
  • Switzerland (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Biomass Energy
  • Biopharma
  • Chemical
  • Cleantech
  • Energy
  • Sustainability
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Valquest Partners frequently co-invest with?

Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
AP
Europe, Rhone-Alpes, France, Lyon
Co-Investments: 1
European Investment Fund
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
Supernova
South America, Parana, Brazil, Curitiba
Co-Investments: 1
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Crédit Mutuel Innovation
Europe, Ile-de-France, France, Paris
Co-Investments: 1
BNP Paribas
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 1
Crédit Agricole
Europe, Ile-de-France, France, Montrouge
Co-Investments: 1
Karista
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by Valquest Partners?

Bloom Biorenewables Ltd

Fribourg, Fribourg, Switzerland

Bloom Biorenewables is making biomass a true alternative to petroleum.

Biomass EnergyBiopharmaChemicalCleanTechEnergySustainability
Series AApr 2, 2025
Amount Raised: $14,717,537
TISSIUM

Paris, Ile-de-France, France

TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.

BiotechnologyHealth CareMedical Device
Series BNov 20, 2019
Amount Raised: $43,204,009
AFYREN

Saint-beauzire, Auvergne, France

AFYREN develop innovation in biotechnologies for the valorization of non-food biomass and in respect of the environment.

Biotechnology
Series UnknownFeb 12, 2019
Amount Raised: $23,801,050